# A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

> **NCT01649024** · PHASE2 · UNKNOWN · sponsor: **Azienda Ospedaliera Universitaria Senese** · enrollment: 29 (actual)

## Conditions studied

- Malignant Mesothelioma

## Interventions

- **DRUG:** Tremelimumab

## Key facts

- **NCT ID:** NCT01649024
- **Lead sponsor:** Azienda Ospedaliera Universitaria Senese
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-05
- **Primary completion:** 2012-06
- **Final completion:** 2013-06
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2012-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01649024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01649024, "A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01649024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*